“The platform has enabled us to develop a pipeline of novel therapeutic programs, targeting tumor-associated macrophages, based on either first-in-class targets or first-in-mechanism ...

In order to address the challenge of sepsis treatment through immune metabolic modulation, the research team led by Prof.

In a new study, researchers have discovered that Tim4, a receptor on macrophages that recognizes apoptotic cells, facilitates the interaction between microplastics and macrophages and hampers an ...

A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition in which affected individuals experience ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the ...

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and ...